1. Home
  2. LEGN vs HMY Comparison

LEGN vs HMY Comparison

Compare LEGN & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • HMY
  • Stock Information
  • Founded
  • LEGN 2014
  • HMY 1950
  • Country
  • LEGN United States
  • HMY South Africa
  • Employees
  • LEGN N/A
  • HMY N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • HMY Precious Metals
  • Sector
  • LEGN Health Care
  • HMY Basic Materials
  • Exchange
  • LEGN Nasdaq
  • HMY Nasdaq
  • Market Cap
  • LEGN 7.0B
  • HMY 7.5B
  • IPO Year
  • LEGN 2020
  • HMY N/A
  • Fundamental
  • Price
  • LEGN $28.91
  • HMY $15.84
  • Analyst Decision
  • LEGN Strong Buy
  • HMY Sell
  • Analyst Count
  • LEGN 13
  • HMY 2
  • Target Price
  • LEGN $75.67
  • HMY $6.60
  • AVG Volume (30 Days)
  • LEGN 1.7M
  • HMY 4.5M
  • Earning Date
  • LEGN 05-13-2025
  • HMY 01-01-0001
  • Dividend Yield
  • LEGN N/A
  • HMY 0.94%
  • EPS Growth
  • LEGN N/A
  • HMY 16.30
  • EPS
  • LEGN N/A
  • HMY 0.88
  • Revenue
  • LEGN $728,303,000.00
  • HMY $3,553,951,394.00
  • Revenue This Year
  • LEGN $64.21
  • HMY $23.09
  • Revenue Next Year
  • LEGN $53.69
  • HMY $14.74
  • P/E Ratio
  • LEGN N/A
  • HMY $17.60
  • Revenue Growth
  • LEGN 112.46
  • HMY 16.84
  • 52 Week Low
  • LEGN $27.34
  • HMY $7.97
  • 52 Week High
  • LEGN $60.87
  • HMY $18.77
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 39.95
  • HMY 55.81
  • Support Level
  • LEGN $28.14
  • HMY $14.92
  • Resistance Level
  • LEGN $31.12
  • HMY $15.75
  • Average True Range (ATR)
  • LEGN 1.87
  • HMY 0.49
  • MACD
  • LEGN -0.16
  • HMY 0.00
  • Stochastic Oscillator
  • LEGN 25.95
  • HMY 75.86

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About HMY Harmony Gold Mining Company Limited

Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.

Share on Social Networks: